| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 13, 2006
Accepted on December 1, 2006
From the Vascular Biology Unit (J.G., J.M., P.C., C.M.), School of Medicine, James Cook University, Townsville; the Laboratory for Genetic Epidemiology (N.S., L.J.P.), Western Australian Institute for Medical Research, Perth; the Department of Vascular Surgery (A.E.D.), Monash University, Box Hill Hospital, Box Hill, Melbourne; and the School of Surgery and Pathology (L.S., P.N.), University of Western Australia, Fremantle Hospital, Fremantle, Australia.
* To whom correspondence should be addressed. E-mail: Jonathan.Golledge{at}jcu.edu.au.
Objectives--In vitro and animal studies have implicated osteopontin (OPN) in the pathogenesis of aortic aneurysm. The relationship between serum concentration of OPN and variants of the OPN gene with human abdominal aortic aneurysm (AAA) was investigated.
Methods and Results--OPN genotypes were examined in 4227 subjects in which aortic diameter and clinical risk factors were measured. Serum OPN was measured by ELISA in two cohorts of 665 subjects. The concentration of serum OPN was independently associated with the presence of AAA. Odds ratios (and 95% confidence intervals) for upper compared with lower OPN tertiles in predicting presence of AAA were 2.23 (1.29 to 3.85, P=0.004) for the population cohort and 4.08 (1.67 to 10.00, P=0.002) for the referral cohort after adjusting for other risk factors. In 198 patients with complete follow-up of aortic diameter at 3 years, initial serum OPN predicted AAA growth after adjustment for other risk factors (standardized coefficient 0.24, P=0.001). The concentration of OPN in the aortic wall was greater in patients with small AAAs (30 to 50 mm) than those with aortic occlusive disease alone. There was no association between five single nucleotide polymorphisms or haplotypes of the OPN gene and aortic diameter or AAA expansion.
Conclusions--Serum and tissue concentrations of OPN are associated with human AAA. We found no relationship between variation of the OPN gene and AAA. OPN may be a useful biomarker for AAA presence and growth.
Related Article:
This article has been cited by other articles:
![]() |
M. Koshikawa, K. Aizawa, H. Kasai, A. Izawa, T. Tomita, S. Kumazaki, H. Tsutsui, J. Koyama, S. Shimodaira, M. Takahashi, et al. Elevated Osteopontin Levels in Patients With Peripheral Arterial Disease Angiology, February 1, 2009; 60(1): 42 - 45. [Abstract] [PDF] |
||||
![]() |
P. E Norman, L. Flicker, O. P Almeida, G. J Hankey, Z. Hyde, and K. Jamrozik Cohort Profile: The Health In Men Study (HIMS) Int. J. Epidemiol., February 1, 2009; 38(1): 48 - 52. [Full Text] [PDF] |
||||
![]() |
J. Golledge, P. S. Tsao, R. L. Dalman, and P. E. Norman Circulating Markers of Abdominal Aortic Aneurysm Presence and Progression Circulation, December 2, 2008; 118(23): 2382 - 2392. [Full Text] [PDF] |
||||
![]() |
B Giusti, C Saracini, P Bolli, A Magi, I Sestini, E Sticchi, G Pratesi, R Pulli, C Pratesi, and R Abbate Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm J. Med. Genet., November 1, 2008; 45(11): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Golledge, M. Karan, C. S. Moran, J. Muller, P. Clancy, A. E. Dear, and P. E. Norman Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions Eur. Heart J., March 1, 2008; 29(5): 665 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study Circulation, November 13, 2007; 116(20): 2275 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scatena, L. Liaw, and C. M. Giachelli Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2302 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shaheen and N. L. Weintraub Osteopontin: A Bona Fide Mediator of Abdominal Aortic Aneurysm? Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 439 - 441. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |